Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model

AIM: To improve anti-inflammatory activity while reducing drug doses, we developed a nanoformulation carrying dexamethasone and butyrate. METHODS: Dexamethasone cholesteryl butyrate-solid lipid nanoparticles (DxCb-SLN) were obtained with the warm microemulsion method. The anti-inflammatory activity...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Gastroenterol
Auteurs principaux: Dianzani, Chiara, Foglietta, Federica, Ferrara, Benedetta, Rosa, Arianna Carolina, Muntoni, Elisabetta, Gasco, Paolo, Della Pepa, Carlo, Canaparo, Roberto, Serpe, Loredana
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2017
Sujets:
Basic Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5483494/
https://ncbi.nlm.nih.gov/pubmed/28694660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i23.4200
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires